Cover
Vol. 6 No. 1 (2016)

Published: June 30, 2016

Pages: 45-60

Research Article

Effects of Metformin on Sperm Parameters in Mice: as a model for human being

Abstract

Background: Metformin is anti-hyperglycemic effect due to decrease of hepatic glucose production. Another effect, leading decrease insulin resistance, regarded a safe drug, treatment of choice for overweight. Objective: To investigate the effects of 3 concentration of MF administered orally to male mice on sperm parameters as model for human being. Materials and Methods: In current study, 80 male mice were taken with age ranging between 1.5-2 month and weights ranging between 25-30 grams males classified into four groups of a control group (G1) and treated group (G2, G3 and G4) doses of MF were employed, 0.2, 0.4, 0.6 mg/mice daily to groups, given orally for 6 weeks and then the animals were scarified. Results Results have revealed a significant difference (P < 0.05) in sperm concentration for 3 groups compared to G1 group. Progressive motility (%) appeared with significant difference (P< 0.05) for G3 group as compared to other treated and G1 group. Furthermore, the result illustrated a significant decreased (P< 0.05) in the abnormal sperm morphology for G3 group compared with treated and control. However, sperm agglutination (%) confirmed that the G3 group exhibited highly statistical significant decrease (p≤0.001) compared to G1, G2 and G4. Conclusions From results of the present study, it was concluded that the administration of MF doses reduce sperm concentration .while, 0.4mg dose improve certain sperm parameters.

References

  1. Nathan DM, Buse JB, Davidson MB, et al Medical management of hyperglycemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy .A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes .Diabetologia. 2009; 52:17–30.
  2. Palomba S, Falbo A, Zullo F, et al. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocrine Reviews 2009;301–350.
  3. Hermann L and Melander A. Biguanides : basic aspects and clinical uses, in International Textbook of Diabetes Mellitus (Alberti KGMM, DeFronzo RA, Keen H and Zimmet P eds),John Wiley & Sons Inc. 1992; New York.
  4. Salpeter SR, Greyber E, Pasternak GA, et al. Risk offatal and nonfatal lactic acidosis with metformin use in type 2diabetes 57 mellitus. Cochrane Database Syst Rev, Issue4 Art. 2010;no.: CD002967.doi:10.1002/14651858. CD002967.pub.
  5. Noto H, Goto A, Tsujimoto T, et al. Cancer risk in diabetic patients treated with metformin: a systematic review and meta- analysis. PLoS One 2012;7:e33411.
  6. Libby G, Donnelly LA, Donnan PT, et al. new users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 2009; 32:1620–1625. 6. Mayes MA, Laforest MF, Guillemette C, et al. Adenosine 5'- monophosphate kinase-activated protein kinase (PRKA) activators delay meiotic resumption in porcine oocytes. Biol. Reprod. 2007; 76:589-597.
  7. Tosca L, Uzbekova S, Chabrolle C, et al. Possible role of 5' AMP-activated protein kinase in the metformin-mediated arrest of bovine oocytes at the germinal vesicle stage during in vitro maturation. Bio. Reprod 2007; 77:452-465.
  8. Tosca L, Uzbekova S, Chabrolle C, et al. Possible role of 5' AMP-activated protein kinase in the metformin-mediated arrest of bovine oocytes at the germinal vesicle stage during in vitro maturation. Bio. Reprod 2007; 77:452-465.
  9. Malik P, Kemmler G, Hummer M, et al. EUFEST Study Group: Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial. J Clin. Psychopharmacology 2011; 31:274– 280.
  10. Lenhard JM, Kliewer SA, Paulik MA, et al. Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways .Biochemical Pharmacology 1997 54 801–808.
  11. Junquira LC, and Carneiro J. Male genital system in Basic histology. Text book and atlas.11th edition. 2005; Pp: 418 - 429.
  12. Mills SE. Testis and Excretory duct system .In Histology for Pathologists, 3rd Edition. 2007; Pp: 945-956.
  13. Ross MH and Pawlina W. Histology a text and atlas, with correlated cell and molecular biology, 5th edition. 2006; Pp: 73.
  14. Williams S F: Mouse In: Practical Guide to Laboratory Animals. The C. V. Mosby Company. Saint Louis.1986; Pp: 44-47.
  15. Ganong, W. F. : The gonads. In: Review of Medical Physiology. Ganong, W. F. (Eds).1991.
  16. Baltimore, M. and Alabama B. : Report on optimal evaluation of the infertile male. Fertil. Sterile.2004; 82: 543-549.
  17. Baxendale R W and Fraser L R. : Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation. Mol. Reprod. Dev.2005; 71: 495-508.
  18. Hinting A. : Method of semen analysis. In: Assessment of human Sperm fertilizing ability. Ph. D. Thesis Rijksuniversiteit Gent, Belgium.1989; PP: 281-288.
  19. Al-Taii H A. : Sperm Activation and Intrauterine Insemination: The Effect of Serum Concentrations and Culture Media on Sperm.1994.
  20. Ayala C, Steinberger E and Smith DP. The influence of semen analysis parameters on the fertility potential of infertile couples. J.Androl.1996; 17(6):718-725.
  21. Campana A, Sakkas D, Stalberg A, et al. : Intrauterine insemination: evaluation of the results according to the woman's age, I i J l f E b d I f ili R h V l (6) S i l I 58 sperm quality,and total sperm count per insemination and life table analysis. Hum.Reprod.1996; 11:732- 6.
  22. Khorram O, Patrizio P, Wang C C, et al. : Reproductive technologies for male infertility. J. Clin. Endocr. Metab 2001; 86: 2373- 2379.
  23. Comhaire F, Milingos S, Liapi A, et al. : The effective cumulative pregnancy rate of different modes of treatment of male infertility. Andrologia.1995; 27: 217- 221.
  24. The UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet 1998; 352:854-865.
  25. Brassøe R, Elkmann T, Hempel M C H. Fulminant lactic acidosisin two patients with Type 2 diabetes treated with metformin Diabet Med. 2005;22(10): 1451-3.
  26. Galardo MN, Riera MF, Pellizzari EH, et al. The AMP-activated protein kinase activator, 5-aminoimidazole-4- carboxamide-1-b-D-ribonucleoside, regulates lactate production in rat Sertoli cells. J Mol Endocrinol. 2007; 39:279-288.
  27. Defronzo RA, Goodman AM. The Multicenter Metformin Study Group. 59 Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 541–549.
  28. Ting RZ, Szeto CC and Chan MH Risk factors of vitamin B (12) deficiency in patients receiving metformin. Arch Intern Med 2006;166:1975–1979
  29. Lamanna C, Mon.ami M, Marchionni N, et al. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials. Diabetes Obes. Metab.2011;13,221–228).
  30. Kayampilly PP, Menon KM. Follicle-stimulating hormone inhibits adenosine5′- monophosphate-activated protein kinase activation and promotes cell proliferation of primary granulosa cells in culture through an Akt- dependent pathway. Endocrinology 2009; 2:929–935.
  31. Welsh M, Saunders PT, Fisken M, et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest 2008; 118:1479–1490.
  32. Oliveira PF, Alves MG, Rato L, et al.. Effect of insulin deprivation on metabolism and metabolism- associated gene transcript levels of in vitro cultured human Sertoli cells. Biochim Biophys Acta (2012);1820: 84–89.
  33. Tartarin P, Moison D, Guibert E, et al. Metformin exposure affects human and mouse fetal testicular cells. Hum Reprod 2012; 27: 3304.
  34. Adaramoye O, Akanni O, Adesanoye O, et al. Evaluation of toxic effects of metformin hydrochloride and glibenclamide on some organs of male rats. Nig J Phys Sci . (2013); 27:137–144. 60